Gryphon-Backed Metagenics Acquires UK Probiotic Brand Symprove
January 23, 2026
Gryphon Investors-backed Metagenics has acquired Symprove, a UK-based probiotic brand, from bd-capital. The deal — terms undisclosed — was completed alongside a strategic debt recapitalization to provide Metagenics with additional capital for organic investment and future M&A; Symprove will continue to be led by CEO Will Bowler.
- Buyers
- Metagenics, Gryphon Investors
- Targets
- Symprove
- Sellers
- bd-capital
- Platforms
- Metagenics
- Industry
- Consumer Products
- Location
- United Kingdom
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
Gryphon Investors Acquires Metagenics from Alticor
December 1, 2021
Consumer Products
Gryphon Investors signed a definitive agreement to acquire Metagenics, Inc. from Alticor, with the transaction expected to close in Q4 2021. WhiteHorse Capital provided a first-lien credit facility to Meta Buyer, LLC to support the acquisition; Gryphon will partner with Metagenics' management to invest in global growth, including potential strategic acquisitions.
-
PanTheryx Acquires TruBiotics Brand from Bayer HealthCare LLC
March 1, 2021
Food & Beverage
PanTheryx, a Phoenix-based nutrition and biotechnology company, acquired the TruBiotics probiotic supplement brand and related trademarks from Bayer HealthCare LLC. The acquisition adds a recognized probiotics brand to PanTheryx’s portfolio to expand its digestive and immune health product lines and to accelerate growth through existing retail and e‑commerce channels.
-
Maven Invests Growth Capital in Covestus; Covestus Acquires Probio7
July 19, 2024
Consumer Products
Maven Investor Partners, via Maven and SWIF Maven Equity Finance (part of the South West Investment Fund), has made a growth capital investment in Cheltenham-based Covestus to support its buy-and-build strategy. The funding will help Covestus scale its portfolio of consumer healthcare brands and has enabled the acquisition of probiotic supplement brand Probio7.
-
ARCHIMED Acquires and Merges Symbio and Proinnovera to Form Symbio Proinnovera
November 17, 2023
Healthcare Services
ARCHIMED has acquired US-based Symbio and Germany-based Proinnovera in an all-equity deal and merged them to create Symbio Proinnovera, a specialized dermatology-focused CRO. The combined group will offer end-to-end dermatology consulting, formulation, testing and clinical research across North America and Europe, with founders rolling equity into the new platform and ARCHIMED-appointed operating partners joining the board to drive growth and further acquisitions.
-
Kadenwood Acquires Probulin Probiotic Brand from HempFusion Wellness
January 18, 2023
Food & Beverage
Kadenwood, a Newport Beach-based plant‑based wellness company, has acquired Probulin, a probiotic and microbiome health brand previously owned by HempFusion Wellness, Inc. The deal expands Kadenwood’s portfolio into the probiotics category and adds retail and e‑commerce distribution channels to accelerate growth across natural, drug and mass retail outlets.
-
Sumeru Equity Partners Invests $70M Growth Round in iProov
January 6, 2022
Cybersecurity
Sumeru Equity Partners committed $70 million in growth capital to iProov to accelerate the biometric face-authentication provider’s expansion in the United States and internationally. The investment will support product and partner-network growth, hiring, and scaling of iProov’s Genuine Presence and Liveness Assurance technologies.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.